Supply and market disruption refers to coordinated strategies aimed at reducing the production, trafficking, distribution, and availability of illicit substances. These strategies often involve law enforcement, regulatory controls, border management, and financial investigations designed to disrupt drug trafficking networks and weaken illicit drug markets. By targeting supply chains and market dynamics, these efforts aim to reduce the availability of drugs, increase the risks and costs associated with illegal production and distribution, and contribute to broader efforts to reduce substance-related harms. Effective supply and market disruption typically operates alongside public health, prevention, treatment, and recovery responses as part of a comprehensive approach to substance use.
Supply & Market Disruption
Ketamine in Europe
Objective: This webinar aims to provide insights into the European ketamine market and will expand on health-related harms caused by non-medical ketamine use.
2026 National Drug Control Strategy - The White House
Global Organized Crime Index 2025 - Europe Overview
Policy Brief: Scam Centres – Combating a Global Phenomenon
Prescription drugs regulations
Adfam organises forum events for practitioners and professionals with an interest in supporting families affected by substance use or gambling.
At each forum we focus on a unique topic relating to families and substance use, inviting a guest speaker with expertise in that topic, followed by a Q&A and wider discussion.
EUDA webinar: International drug checking day
Objective: Taking place on the eve of International Drug Checking Day, this webinar offers a timely opportunity to highlight the role drug-checking services play across three domains: harm reduction, drug market monitoring and public health alerts. The session will demonstrate the benefits of drug checking for a variety of stakeholders, including consumers, public health authorities and monitoring bodies.
Perceptions of Law Enforcement Personnel and Public Health Professionals on Synthetic Drug Use in Nigeria
Drug Supply Reduction: an Overview of EU Policies and Measures
Paris Pact - Phase IV and the Vienna Declaration
The Global SMART Programme — A Strategic Response to the Synthetic Drug Problem, United Nations, New York